Opaleye Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-100,000	Closed	-$4.68M	–	37
2017 Q3	$4.68M	Hold	100,000	–	–	1.66%	21
2017 Q2	$3.6M	Hold	100,000	–	–	1.5%	20
2017 Q1	$3.08M	Buy	100,000 +10,000	+11%	+$308K	1.53%	22
2016 Q4	$3.02M	Buy	+90,000	New	+$3.02M	1.78%	21